Bert Eussen
Impact in
- Ophthalmology top 2%
- Ocular Oncology and Treatments
-
- Immunotherapy and Immune Responses
Papers in ⓘ
-
- Pluripotent Stem Cells Research 3
- Genomics and Chromatin Dynamics 2
-
- Ocular Oncology and Treatments 6
- Co-authors
- Annelies de Klein (14 shared papers)Dion Paridaens (6 shared papers)Emine Kılıç (6 shared papers)Jolanda Vaarwater (6 shared papers)Robert M. Verdijk (5 shared papers)Serdar Yavuzyiğitoğlu (4 shared papers)Anna E. Koopmans (2 shared papers)Harmen J.G. van de Werken (4 shared papers)
- Journals
- Stem Cell Research (4 papers)Ophthalmology (2 papers)Cancers (1 paper)Nature Cell Biology (1 paper)Human Molecular Genetics (1 paper)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Bert Eussen
18 papers receiving 566 citations
Peers
Comparison fields: 5 of 51
- Ophthalmology 241
- Immunology 111
- Molecular Biology 317
- Oncology 109
- Genetics 92
Countries citing papers authored by Bert Eussen
This map shows the geographic impact of Bert Eussen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bert Eussen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bert Eussen more than expected).
Fields of papers citing papers by Bert Eussen
This network shows the impact of papers produced by Bert Eussen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bert Eussen. The network helps show where Bert Eussen may publish in the future.
Co-authors
The 25 scholars most cited alongside Bert Eussen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 190 | |
| 2 | 2011 | 120 | |
| 3 | 1994 | 54 | |
| 4 | 2010 | 39 | |
| 5 | 1992 | 26 | |
| 6 | 2021 | 24 | |
| 7 | 2016 | 24 | |
| 8 | 2018 | 19 | |
| 9 | 2013 | 15 | |
| 10 | 2022 | 13 | |
| 11 | 2019 | 12 | |
| 12 | 2010 | 10 | |
| 13 | 2018 | 6 | |
| 14 | 2019 | 5 | |
| 15 | 2018 | 5 | |
| 16 | 2024 | 3 | |
| 17 | 2019 | 3 | |
| 18 | 1999 | 1 |
About Bert Eussen
Bert Eussen is a scholar working on Molecular Biology, Ophthalmology, Surgery, Genetics and Oncology, having authored 18 papers that have together received 569 indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (6 papers), Genomic variations and chromosomal abnormalities (4 papers), Immunotherapy and Immune Responses (3 papers), Pluripotent Stem Cells Research (3 papers), Cutaneous Melanoma Detection and Management (2 papers), Tissue Engineering and Regenerative Medicine (2 papers), Genomics and Chromatin Dynamics (2 papers) and Genetic Neurodegenerative Diseases (2 papers). The work is most often cited by research in Ophthalmology (241 citations), Immunology (111 citations), Molecular Biology (317 citations), Oncology (109 citations) and Genetics (92 citations). Bert Eussen has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Annelies de Klein, Dion Paridaens, Emine Kılıç, Jolanda Vaarwater, Robert M. Verdijk, Serdar Yavuzyiğitoğlu, Anna E. Koopmans, Harmen J.G. van de Werken, Marieke Simonis and Petra Klous. Their work appears in journals such as Stem Cell Research, Ophthalmology, Cancers, Nature Cell Biology and Human Molecular Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.